These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 22935585)
21. How I treat hypereosinophilic syndromes. Klion AD Blood; 2009 Oct; 114(18):3736-41. PubMed ID: 19692700 [TBL] [Abstract][Full Text] [Related]
22. Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update. Tefferi A; Gotlib J; Pardanani A Mayo Clin Proc; 2010 Feb; 85(2):158-64. PubMed ID: 20053713 [TBL] [Abstract][Full Text] [Related]
23. Omalizumab modulates bronchial reticular basement membrane thickness and eosinophil infiltration in severe persistent allergic asthma patients. Riccio AM; Dal Negro RW; Micheletto C; De Ferrari L; Folli C; Chiappori A; Canonica GW Int J Immunopathol Pharmacol; 2012; 25(2):475-84. PubMed ID: 22697079 [TBL] [Abstract][Full Text] [Related]
24. Mepolizumab and eosinophil-mediated disease. Walsh GM Curr Med Chem; 2009; 16(36):4774-8. PubMed ID: 19929788 [TBL] [Abstract][Full Text] [Related]
25. What targeting eosinophils has taught us about their role in diseases. Bochner BS; Gleich GJ J Allergy Clin Immunol; 2010 Jul; 126(1):16-25; quiz 26-7. PubMed ID: 20434203 [TBL] [Abstract][Full Text] [Related]
34. Treatment of a case of pediatric hypereosinophilic syndrome with anti-interleukin-5. Mehr S; Rego S; Kakakios A; Kilham H; Kemp A J Pediatr; 2009 Aug; 155(2):289-91. PubMed ID: 19619754 [TBL] [Abstract][Full Text] [Related]
36. Omalizumab as a steroid-sparing agent in chronic eosinophilic pneumonia. Kaya H; Gümüş S; Uçar E; Aydoğan M; Muşabak U; Tozkoparan E; Bilgiç H Chest; 2012 Aug; 142(2):513-516. PubMed ID: 22871762 [TBL] [Abstract][Full Text] [Related]
37. Anti-IgE treatment of eosinophil-associated gastrointestinal disorders. Foroughi S; Foster B; Kim N; Bernardino LB; Scott LM; Hamilton RG; Metcalfe DD; Mannon PJ; Prussin C J Allergy Clin Immunol; 2007 Sep; 120(3):594-601. PubMed ID: 17765756 [TBL] [Abstract][Full Text] [Related]
38. Targeting interleukin (IL) 5 for asthma and hypereosinophilic diseases. Stein ML; Munitz A Recent Pat Inflamm Allergy Drug Discov; 2010 Nov; 4(3):201-9. PubMed ID: 20807192 [TBL] [Abstract][Full Text] [Related]